US2007122490A1PendingUtilityA1

Wound healing compound

Individually held — no corporate assignee on recordPriority: Oct 12, 2000Filed: Dec 26, 2006Published: May 31, 2007
Est. expiryOct 12, 2020(expired)· nominal 20-yr term from priority
Inventors:Mickey Peshoff
A61K 31/59A61K 31/65A61K 31/7048A61K 31/545A61K 31/7034A61K 45/06A61K 31/43A61K 33/30A61K 31/665
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprise a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound healing composition alone. In one embodiment, the wound healing composition comprises (a) zinc oxide and (b) fat-soluble vitamins. The therapeutic antibacterial/antifungal-wound healing compositions may be utilized in a wide variety of pharmaceutical products. This invention also relates to methods for preparing and using the antibacterial/antifungal-wound healing compositions and the pharmaceutical products in which the therapeutic compositions may be used.

Claims

exact text as granted — not AI-modified
1 - 17 . (canceled)  
   
   
       18 . A wound healing composition for repairing human tissue adapted for oral and non-oral administration, comprising: a therapeutically effective mixture of zinc oxide and at least two fat-soluble vitamins admixed with a pharmaceutically acceptable carrier.  
   
   
       19 . The composition of  claim 18 , wherein said fat-soluble vitamins comprise at least Vitamins A and D  
   
   
       20 . The composition of  claim 18 , further comprising therapeutically effective amounts of antibacterial and antifungal agents.  
   
   
       21 . The composition of  claim 18 , further comprising therapeutically effective amounts of Vitamins E and K.  
   
   
       22 . The composition of  claim 18 , wherein the therapeutically effective mixture comprises between about 0.01% and about 75% by total weight of zinc oxide.  
   
   
       23 . The composition of  claim 19 , wherein said therapeutically-effective mixture comprises between about 0.01% and 99.99% by total weight of fat-soluble vitamins.  
   
   
       24 - 37 . (canceled)

Join the waitlist — get patent alerts

Track US2007122490A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.